DB15455Investigational
Cenersen is under investigation in clinical trial NCT02243124 (A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)).
Resolves to
Compound
Targets
What you can answer from here — as of April 23, 2025
Which drugs share a target with Cenersen, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account